CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: In conclusion, we can reasonably speculate that all the 26 genes over expressed at diagnosis led to the up-regulation of the cell cycle in CML CD34+/lin- cells at diagnosis increasing their survival with respect to 12 months of nilotinib treatment.